B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Aberrant regulation of mitotic cell cycle due to RB1 defects

REACTOME PATHWAY
Reactome: R-HSA-96871394 genes11 compounds

The Aberrant regulation of mitotic cell cycle due to RB1 defects pathway (Reactome ID: R-HSA-9687139) involves 4 genes and is affected by 11 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

CCNE2CDK2CDK4CDK6

Compounds Affecting Aberrant regulation of mitotic cell cycle due to RB1 defects

#CompoundTargets HitStudies
1indirubin300
2alsterpaullone12
3kenpaullone8
4Apigenin 5,7,4'-trihydroxy-flavone,300
5chrysin300
6fisetin78
7Sorafenib300
8Aurintricarboxylic Acid184
9Methylergonovine14
10sp600125117
11Adenosine Triphosphate300

About the Aberrant regulation of mitotic cell cycle due to RB1 defects Pathway

The Aberrant regulation of mitotic cell cycle due to RB1 defects pathway is catalogued in Reactome (ID: R-HSA-9687139) and involves 4 genes. In the BiohacksAI corpus, 11 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include CCNE2, CDK2, CDK4, CDK6.